Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
Watch
on air now

Create a 3AW account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 3AW content and other benefits.


Joining is free and easy.

You will soon need to register to keep streaming 3AW online. Register an account or skip for now to do it later.

Advertisement
Advertisement
Advertisement

Federal Health Minister makes a confronting admission

Tom Elliott
Article image for Federal Health Minister makes a confronting admission

The Federal Health Minister has admitted the sluggish approval process for new medical treatments means there are people dying who need not die.

Press PLAY below to hear his confronting admission (or scroll down to listen to the full interview)

Health Minister Mark Butler told Neil Mitchell we’re in a “turbocharged period of discovery” for new medical treatments — particularly cell and gene therapies such as CAR T therapy — and the process to make them available to the public is lagging behind.

NEIL MITCHELL: “You do accept people are dying who need not die … do you accept that? I know you don’t want to say it as a politician but it’s fact, isn’t it?”

MARK BUTLER:Well it is a fact and I don’t like saying it because none of us like considering this.”

A review into Australia’s medical approval process is currently underway and is due to be completed at the end of 2023.

“I think it is clear to me, and to most frankly, that system is a little clunky in terms of dealing with just the speed of technology that’s coming through,” Mr Butler said.

Press PLAY below to hear the full interview on the “turbocharged” era of medical discovery and Australia’s medical approval process

Neil Mitchell’s life-saving campaign to make cancer ‘holy grail’ available for all

Image (inset): Martin Ollman/Getty Images / (background): Adobe Stock

Tom Elliott
Advertisement